Global Biologics and Biosimilars Market Analysis 2013-2018 and Forecast 2019-2024
Report ID: 106053 | Mar 2019 | No. of Pages: 107
|
Snapshot
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.
The global Biologics and Biosimilars market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biologics and Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Antibody
Hormone
Growth Factors
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.
The global Biologics and Biosimilars market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biologics and Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Antibody
Hormone
Growth Factors
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Biologics and Biosimilars Industry
1.1.1 Overview
1.1.2 Development of Biologics and Biosimilars
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Biologics and Biosimilars Market by Type
3.1 By Type
3.1.1 Antibody
3.1.2 Hormone
3.1.3 Growth Factors
3.1.4 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.Biologics and Biosimilars Roche (Company Profile, Sales Data etc.)
4.2 Amgen (Company Profile, Sales Data etc.)
4.3 AbbVie (Company Profile, Sales Data etc.)
4.4 Sanofi-Aventis (Company Profile, Sales Data etc.)
4.5 Johnson & Johnson (Company Profile, Sales Data etc.)
4.6 Pfizer (Company Profile, Sales Data etc.)
4.7 Novo Nordisk (Company Profile, Sales Data etc.)
4.8 Eli Lilly (Company Profile, Sales Data etc.)
4.9 Novartis (Company Profile, Sales Data etc.)
4.10 Merck (Company Profile, Sales Data etc.)
4.11 3sbio (Company Profile, Sales Data etc.)
4.12 Changchun High Tech (Company Profile, Sales Data etc.)
4.13 CP Guojian (Company Profile, Sales Data etc.)
4.14 Biotech (Company Profile, Sales Data etc.)
4.15 Gelgen (Company Profile, Sales Data etc.)
4.16 Innovent (Company Profile, Sales Data etc.)
4.17 Dong Bao (Company Profile, Sales Data etc.)
4.18 Ganlee (Company Profile, Sales Data etc.)
4.19 United Laboratories (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Tumor
6.1.2 Demand in Diabetes
6.1.3 Demand in Cardiovascular
6.1.4 Demand in Hemophilia
6.1.5 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
LIST OF TABLE
Table Upstream Segment of Biologics and Biosimilars
Table Application Segment of Biologics and Biosimilars
Table Global Biologics and Biosimilars Market 2013-2024, by Application, in USD Million
Table Major Company List of Antibody
Table Major Company List of Hormone
Table Major Company List of Growth Factors
Table Major Company List of Others
Table Global Biologics and Biosimilars Market 2013-2018, by Type, in USD Million
Table Global Biologics and Biosimilars Market Forecast 2019-2024, by Type, in USD Million
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3sbio Overview List
Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Changchun High Tech Overview List
Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CP Guojian Overview List
Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biotech Overview List
Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gelgen Overview List
Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Innovent Overview List
Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dong Bao Overview List
Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ganlee Overview List
Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Laboratories Overview List
Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Biologics and Biosimilars Sales Revenue 2013-2018, by Company, in USD Million
Table Global Biologics and Biosimilars Sales Revenue Share, by Company, in USD Million
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Biologics and Biosimilars Demand Forecast 2019-2024, by Application, in USD Million
Table Biologics and Biosimilars Production 2013-2018, by Region, in USD Million
Table Global Biologics and Biosimilars Market 2013-2018, by Region, in USD Million
Table Global Biologics and Biosimilars Market Share 2013-2018, by Region, in USD Million
Table North America Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table Europe Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table South America Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table Biologics and Biosimilars Market Forecast 2019-2024, by Region, in USD Million
Table Price Factors List
LIST OF FIGURES
Figure Global Biologics and Biosimilars Market Growth 2013-2018, by Type, in USD Million
Figure North America Biologics and Biosimilars Market Concentration, in 2018
Figure Europe Biologics and Biosimilars Market Market Concentration, in 2018
Figure Asia-Pacific Biologics and Biosimilars MMarket Concentration, in 2018
Figure South America Biologics and Biosimilars Market Concentration, in 2018
Figure Middle East & Africa Biologics and Biosimilars Market Concentration, in 2018
Figure Biologics and Biosimilars Demand in Tumor, 2013-2018, in USD Million
Figure Biologics and Biosimilars Demand in Diabetes, 2013-2018, in USD Million
Figure Biologics and Biosimilars Demand in Cardiovascular, 2013-2018, in USD Million
Figure Biologics and Biosimilars Demand in Hemophilia, 2013-2018, in USD Million
Figure Biologics and Biosimilars Demand in Others, 2013-2018, in USD Million
Figure North America Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure Europe Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure South America Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure Marketing Channels Overview
1 Industry Overview
1.1 Biologics and Biosimilars Industry
1.1.1 Overview
1.1.2 Development of Biologics and Biosimilars
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Biologics and Biosimilars Market by Type
3.1 By Type
3.1.1 Antibody
3.1.2 Hormone
3.1.3 Growth Factors
3.1.4 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.Biologics and Biosimilars Roche (Company Profile, Sales Data etc.)
4.2 Amgen (Company Profile, Sales Data etc.)
4.3 AbbVie (Company Profile, Sales Data etc.)
4.4 Sanofi-Aventis (Company Profile, Sales Data etc.)
4.5 Johnson & Johnson (Company Profile, Sales Data etc.)
4.6 Pfizer (Company Profile, Sales Data etc.)
4.7 Novo Nordisk (Company Profile, Sales Data etc.)
4.8 Eli Lilly (Company Profile, Sales Data etc.)
4.9 Novartis (Company Profile, Sales Data etc.)
4.10 Merck (Company Profile, Sales Data etc.)
4.11 3sbio (Company Profile, Sales Data etc.)
4.12 Changchun High Tech (Company Profile, Sales Data etc.)
4.13 CP Guojian (Company Profile, Sales Data etc.)
4.14 Biotech (Company Profile, Sales Data etc.)
4.15 Gelgen (Company Profile, Sales Data etc.)
4.16 Innovent (Company Profile, Sales Data etc.)
4.17 Dong Bao (Company Profile, Sales Data etc.)
4.18 Ganlee (Company Profile, Sales Data etc.)
4.19 United Laboratories (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Tumor
6.1.2 Demand in Diabetes
6.1.3 Demand in Cardiovascular
6.1.4 Demand in Hemophilia
6.1.5 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
LIST OF TABLE
Table Upstream Segment of Biologics and Biosimilars
Table Application Segment of Biologics and Biosimilars
Table Global Biologics and Biosimilars Market 2013-2024, by Application, in USD Million
Table Major Company List of Antibody
Table Major Company List of Hormone
Table Major Company List of Growth Factors
Table Major Company List of Others
Table Global Biologics and Biosimilars Market 2013-2018, by Type, in USD Million
Table Global Biologics and Biosimilars Market Forecast 2019-2024, by Type, in USD Million
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3sbio Overview List
Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Changchun High Tech Overview List
Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CP Guojian Overview List
Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biotech Overview List
Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gelgen Overview List
Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Innovent Overview List
Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dong Bao Overview List
Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ganlee Overview List
Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Laboratories Overview List
Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Biologics and Biosimilars Sales Revenue 2013-2018, by Company, in USD Million
Table Global Biologics and Biosimilars Sales Revenue Share, by Company, in USD Million
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Biologics and Biosimilars Demand Forecast 2019-2024, by Application, in USD Million
Table Biologics and Biosimilars Production 2013-2018, by Region, in USD Million
Table Global Biologics and Biosimilars Market 2013-2018, by Region, in USD Million
Table Global Biologics and Biosimilars Market Share 2013-2018, by Region, in USD Million
Table North America Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table Europe Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table South America Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million
Table Biologics and Biosimilars Market Forecast 2019-2024, by Region, in USD Million
Table Price Factors List
LIST OF FIGURES
Figure Global Biologics and Biosimilars Market Growth 2013-2018, by Type, in USD Million
Figure North America Biologics and Biosimilars Market Concentration, in 2018
Figure Europe Biologics and Biosimilars Market Market Concentration, in 2018
Figure Asia-Pacific Biologics and Biosimilars MMarket Concentration, in 2018
Figure South America Biologics and Biosimilars Market Concentration, in 2018
Figure Middle East & Africa Biologics and Biosimilars Market Concentration, in 2018
Figure Biologics and Biosimilars Demand in Tumor, 2013-2018, in USD Million
Figure Biologics and Biosimilars Demand in Diabetes, 2013-2018, in USD Million
Figure Biologics and Biosimilars Demand in Cardiovascular, 2013-2018, in USD Million
Figure Biologics and Biosimilars Demand in Hemophilia, 2013-2018, in USD Million
Figure Biologics and Biosimilars Demand in Others, 2013-2018, in USD Million
Figure North America Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure Europe Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure South America Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million
Figure Marketing Channels Overview
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. It provides a forward looking perspective on different factors driving or restraining market growth
3. It provides a ten-year forecast assessed on the basis of how the market is expected to grow
4. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segments
Connect With Us
+1-707-633-0404
sales@search4research.com